Wednesday 3 June 2020

Worldwide Analysis on Acupuncture Market Size, share, Trends and Forecast

Acupuncture Market Analysis/Acupuncture Market Trends 
The global acupuncture market size is likely to touch USD 55323.8 million at a 14.50% CAGR between 2018-2023, as per the latest Market Research Future (MRFR) report. Acupuncture is an effective alternative medicine that helps to treat pain through the insertion of needles into the skin. It is usually used with other forms of treatment. Acupuncture is widely used for treating paralysis, speech disorders, insomnia, menstrual cramps, nausea, post-operative pain, joint conditions, and more. 
Numerous factors are adding to the global acupuncture needle market growth. These factors, according to the recent MRFR report, include demand for non-invasive & painless treatment, rising prevalence of migraine & fibromyalgia, increasing incidence of various gynecological disorders, namely menopause, PCOS, infertility, chronic pain disorders, PMS, and pregnancy complaints. Besides, growing demand for alternative & complementary medicine, funding from market contenders & new entrants, and increasing health complications, especially among the elderly population such as sleep disturbances, emotional disorders, rising geriatric population, and body pain, are also adding to the global acupuncture market growth. 
Market Segmentation 
The global acupuncture market is segmented based on end user, product and services, and application. 
By services, the market is segmented into traditional Chinese medicine, scalp acupuncture, Japanese acupuncture, Korean hand acupuncture, cupping, auricular, non-insertion acupuncture, and others. By product, the market is segmented into laser pens, rod lasers, suction pumps, laser needle, needles, and electro-acupuncture device. Of these, services will lead the market over the forecast period for the burgeoning demand for traditional acupuncture therapies. 
By application, the acupuncture market is segmented into pain syndrome illness, psychological illness, gynecological disorders, and others. Of these, the pain syndrome illness market will have a major share in the market during the forecast period. It is likely to develop at a 14.04% CAGR. 
By end user, the market is segmented into wellness center, research and academic institutes, and hospitals & specialty clinics. Among these, the wellness center segment will dominate the market over the forecast period for the increasing use of acupuncture as alternative medicine. 
Regional Analysis 
By region, the global acupuncture market report covers the recent trends and growth opportunities across North America, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, Europe will spearhead the market during the forecast period for the rising prevalence of chronic diseases, increasing use of acupuncture, favorable insurance coverage, and the presence of major market players. Spain, France, and Austria are the leading contributors in the region. The global acupuncture market in this region is predicted to grow at a 13.53% CAGR. 
The global acupuncture market analysis in the Asia Pacific region will have significant growth over the forecast period. Factors adding to the acupuncture market growth include the rising adoption of acupuncture therapies, increasing incidence of chronic disease, and the development of advanced acupuncture products. Korea, Japan, and China are the major contributors in the region. This region is predicted to grow at a 15.02% CAGR. 
Key Players
Eminent players profiled in the global acupuncture market report include Qingdao Great Fortune Co. Ltd, AcuMedic Ltd, Asia med GmbH, 3B Scientific GmbH, SEIRIN Corporation, Kanson, Cymedics GmbH & Co. KG, Ltd, MKW Lasersystem GmbH, schwa-medico GmbH, Wuxi Jiajian Medical Instruments Co., and Zepter International. Industry players have adopted Strategies such as partnerships, acquisitions, and product innovations to create a niche in the market.  
 Industry News
 March 2020: NJ Acupuncture Center is offering HydraFacial, a 30-minute, three-step facial that is ideal for every skin type. It does three things which a healthy skin need- cleanses, hydrates, and extracts. The HydraFacial will treat wrinkles, fine lines, and brown spots and also improve texture, elasticity and firmness, cleanse oily and congested skin, and minimize pores.
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Read Complete Report of Acupuncture Market With 160+ Pages@  https://www.marketresearchfuture.com/reports/acupuncture-market-6139

Related Reports
Aromatherapy Market Information; By Product (Essential Oils (Floral, Citrus, Green/Vegetative, Herbaceous/Camphoraceous, Spicy, Others), Carrier Oils and blended oils), Equipment (Nebulizer Diffuser, Ultrasonic Diffuser, Heat Diffuser), By Application (Tropical, Inhalation, Aerial Diffusion); By Therapeutic Application (Relaxation and Sleep, Pain Management, Skin and Hair Care, Other remedies) - Global Forecast to 2023 : https://www.marketresearchfuture.com/reports/aromatherapy-market-3241
Lab-on-a-Chip Device Market Information: Product (Instruments, Reagents & Consumables), Technology (Microarrays, Microfluidics), Application (Point of Care Diagnostics), and End-User (Biotechnology and Pharmaceutical Companies) – Global Forecast Till 2023: https://www.marketresearchfuture.com/reports/lab-on-a-chip-device-market-6215
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:                                    
Akash Anand                                                                       
Market Research Future
+1 646 845 9312


Spinal Implants and Devices Market- Global Analysis and Forecast to 2023


Market Highlights

Increasing prevalence of spinal stenosis, favorable reimbursement policies, rising demands for minimally invasive therapeutic surgical procedures, and growing geriatric population is estimated to drive the market growth during the forecast period. However, lack of skilled physician, high therapeutic surgery cost and surgery-related complications are estimated to restrain the market growth during the projected period.

Segmentation
The global Spinal Implants and Devices Market is segmented by type, diagnosis, treatment type, and end user.
By type, the market is segmented into lumbar spinal stenosis, cervical stenosis, central stenosis, and others. By diagnosis, the market is categorized into physical examination, imaging, and others. The imaging segment is sub-segmented into magnetic resonance imaging (MRI), computed tomography (CT), X-ray, and others. By treatment type, the market is segmented into surgical treatment, and non-surgical treatment. The surgical treatment market is segmented into foraminotomy, laminotomy, interspinous process spacer, microendoscopic decompression, and others. By end user, the market is segmented into hospitals, ambulatory surgical centers, rehabilitation centers, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:                                    
Akash Anand                                                                       
Market Research Future
+1 646 845 9312


Updates: Spirometry Market Share, Trends, Analysis, Global Growth and Forecast


Global Spirometry Market Share Research Report, by Product (Table-top Spirometry, Hand-held Spirometry, Desktop Spirometry), by Technology (PFM, Volume Measurement Spirometry, Flow Measurement Spirometry), by Application (Diagnostic, Treatment Monitoring), by End-user (Hospitals & Clinics, Home Care, Diagnostic Centers, Research & Academic Institutes), and Region - Forecast to 2023
Get More Details, You can Download Free Sample @ https://www.marketresearchfuture.com/sample_request/6539
Overview:
The global Spirometry market is witnessing a significant rise in its revenues, mainly due to the rising occurrences of respiratory diseases such as asthma and COPD. Besides, the growing rate of diagnosis processes conducted for the detection of interstitial pulmonary fibrosis fosters the growth of the market. Moreover, the increasing exposure to risk factors and the ever-increasing population is driving a large share of the market.
Market Insights
According to the reports published by Market Research Future Reports, the global Spirometry Market size is probable to exhibit a 10.03% CAGR from 2018 to 2023 and is also on the verge to reach USD 1,106.76 million by 2023. Such a humongous market growth can be attributed to the strident rise in the cases of chronic obstructive pulmonary disorders (COPD) and asthma.
Spirometry is considered as a basic test, which is conducted by clinicians to estimate the status of lungs. It is an essential test for diagnosing asthma, COPD, and other breathing disorders.  Thus, spirometers are used to carry out the tests.
Global Spirometry Market: Drivers & Trends
The factors such as emerging chronic respiratory diseases globally, increasing global aging population, and technological shifts in spirometer devices toward smartphone-based data connectivity and analysis are expected to drive the global spirometry market exponentially during the forecast period. With that, emerging economies with growing industrialization are also contributing to driving the market with opportunities for the future in substantial ways.
More stimulating factors such as government initiatives to restrain smoking habits of people, focus on breathing diseases, rising levels of air pollution, and expanding awareness towards the adoption of spirometers at homes are noticeably auguring the global spirometry market growth. Even awareness of reimbursement policies among the public and clinicians are also projecting to be the drivers for patients towards taking these tests. On the flip side, the high costs of spirometers may act as a restrictive factor against the market and hinder the global spirometry market growth.
Furthermore, the rising geriatric population is also anticipating being the factors for the increase in the demand for spirometers to analyze respiratory patterns. The need for spirometers is also probable in the rise due to a high number of surgeries in hospitals and clinics. These factors are tremendously driving the global spirometry market to rise high at a higher CAGR in the years to come.
Segmental Overview
According to the reports published by MRFR, the global spirometry market has been segmented by product, technology, application, and end-user.
By the mode of products, the market includes table-top spirometry, hand-held spirometry, and desktop (PC) spirometry.
By the mode of technology, the market has been segmented into volume measurement spirometry, peak flow meters (PFM), and flow measurement spirometry.
By the mode of application, the spirometry market is segmented into diagnostic and treatment monitoring.
Moreover, by the mode of end-users, the market includes research & academic institutes, diagnostic centers, hospitals & clinics, and home care.
Regional Outlook
Geographically, the market of spirometry has covered some main regions such as Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
Among these, Asia Pacific is expected to register the highest CAGR for the market to proliferate during the forecast period. Growth of this market in the Asia Pacific region is driven mainly by the large population of the patient and a high prevalence of chronic respiratory diseases.
While North America has the largest market for spirometers owing to technological advancements, government regulations, rise in incidences of respiratory diseases, increasing healthcare expenditure, and improved healthcare infrastructure.
Key Players
In the end, here are the prominent players in the spirometry market, they are Carefusion Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (U.S.), Vitalograph (U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (U.S.), Midmark Corporation (U.S.), Smiths Medical Inc. (U.S.), and Koninklijke Philips N.V. (The Netherlands).
Read Complete Report of Spirometry Marrket  With 120 Pages @
 NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:                                    
Akash Anand                                                                       
Market Research Future
+1 646 845 9312

Cardiovascular Application Market by Application, By Type, by End User and Region


According to MRFR, Global Cardiovascular Application Market Growth: Information by Device (Cardiac Monitors, Cardiac Pacemakers And Cardiac Defibrillators), End User (Hospitals, Cardiac Care Centers, Ambulatory Centers & Home Care and Academic Centers) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2023
Market Synopsis:
As per Market Research Future (MRFR)’s assessment, the global cardiovascular applications market is set to strike a CAGR of 7.24% during the forecast period 2017 to 2023. Its valuation has been estimated to reach USD 36730.5 Mn mark towards the end of 2023. In the U.S., one out of every four deaths was caused due to heart ailment in 2015 according to the Centers for Disease Control & Prevention. Every corner of the world is largely affected by the burden of cardiovascular diseases. This, in turn, has opened new avenues of growth opportunities to capitalize on for the key players and researchers.
A major proportion of global healthcare expenditure is attributed to the large-scale presence of heart diseases. The rise in these expenditures is directly proportional to the growth of the cardiovascular application market. In addition, the population of people over the age group of 50 years is the most vulnerable to CVDs. According to published statistics by the World Health Organization (WHO), the population of older adults is projected to get doubled between 2015 and 2050. It is anticipated to intensify the growth rate of the cardiovascular application market in the foreseeable future.
Rapid urbanization and modernization have led to a major increase in the working class population. The changing lifestyle and food habits have further contributed to the expansion of the prevalence of these diseases across the world. It has necessitated the development of drugs and treatments for early, more precise and highly effective diagnosis. This, in turn, is presumed to augment the global cardiovascular application market across the review period.
Market Segmentation:
By devices, the global cardiovascular application market has been segmented into cardiac pacemaker, monitors, defibrillators, and others. The monitors segment has been further sub-segmented into resting ECG, holter monitors, ECG monitors, implantable loop recorder, and others. The cardiac pacemaker segment is sub-segmented into implantable cardiac pacemaker, and external cardiac pacemaker. The cardiac defibrillator is further sub-segmented into implantable cardioverter defibrillator, and external defibrillator.

By end users, the cardiovascular application market is segmented into cardiac care centers, academic institutes, ambulatory centers & home care, and others.
Regional Analysis:
The global cardiovascular application market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas, owing to the presence of the U.S. and Canada, has witnessed the early adoption of tech-driven changes in the market. The region is also bestowed with a high population of patients suffering from CVDs or other ailments that cause CVDs. The strong economic growth rate of the region has been influencing the growth of the cardiovascular application market positively owing to high demand for diagnosis. It is expected to secure the pole position in the global market over the assessment period.
Europe trails Americas in terms of market size. The region signifies promising opportunities for the development of the cardiovascular application market. The support extended by its government for the development as well as the adoption of advanced cardiovascular devices is likely to motivate the expansion of the regional market.
Asia Pacific exhibits high demand for cardiovascular applications. The exponential population of aging people is poised to boost the growth trajectory of the market further. It is estimated to strike the highest CAGR through the projection period.
Competitive Dashboard:
General Electric Company, Koninklijke Philips N.V, Abbott, and Medtronic are the prominent players operating in the cardiovascular application market. Other key players profiled in the report are Boston Scientific Corporation (U.S.), Terumo (Japan), Edwards Lifesciences (U.S.), Stryker Corporation (U.S.), Allergan Inc. (U.S.), CR Bard Inc. (U.S.), Sonova Holdings (Switzerland), Smith & Nephew plc (U.K), and Dragerwerk AG & Co. KGa (Germany)
Industry News:
In January 2019, Imec, Medtronic, Ghent University, and seven other partners of the Horizon 2020 CARDIS project have announced the development of a photonics-based medical device which is useful in the easy identification of cardiovascular diseases (CVD) by screening arterial stiffness.
In January 2019, Ireland-based Medtronic has announced the launch of the first mobile application which can communicate directly with smartphone-connected pacemakers.
TABLE 1 PRIMARY INTERVIEWS 20
TABLE 2 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2014 TO 2023 (USD MILLION) 35
TABLE 3 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR CARDIAC MONITORS BY REGION,
2014 TO 2023 (USD MILLION) 36
TABLE 4 GLOBAL CARDIAC MONITORS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 36
TABLE 5 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR CARDIAC MONITORS BY REGION,
2014 TO 2023 (USD MILLION) 37
TABLE 6 GLOBAL CARDIAC PACEMAKERS MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 37
TABLE 7 GLOBAL IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2014 TO 2023 (USD MILLION) 38
TABLE 8 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR CARDIAC DEFIBRILLATORS BY REGION,
2014 TO 2023 (USD MILLION) 38
TABLE 9 GLOBAL CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 39
TABLE 10 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY END USER, 2014 TO 2023 (USD MILLION) 41
TABLE 11 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR HOSPITALS BY REGION,
2014 TO 2023 (USD MILLION) 41
Access Sample Report of Cardiovascular Application Market With 138 Pages @ https://www.marketresearchfuture.com/reports/cardiovascular-application-market-5255
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312

Tuesday 2 June 2020

Demand on Hammertoe Surgery Market Size, Global Trends and Demand

Hammertoe Surgery is a feet disorder wherein the feet permanently bends and is caused due to an imbalance in the muscles and the ligaments. It typically occurs while wearing shoes that are narrow or small-sized. In some cases, hammertoe occurs since birth in some individuals. 
According to the recently published report by Market Research Future (MRFR), the global hammertoe treatment market valuation is expected to reach USD 288.61 million by the end of 2023 from its 2018 valuation of USD 172.51 million. The market is forecasted to exhibit a CAGR of 10.8% during the forecast period of 2018 to 2023. 
The growth of the market, according to the report published by MRFR, is attributed to the rising prevalence of arthritis. 
Market Segmentation
The hammertoe market segmentation is classified into four key dynamics: type, end-user, treatment and diagnosis, and region.
By type, the market divides into flexible and rigid segments. It is reported that the rigid segment is anticipated to garner a CAGR of 11.2% during the forecast period. On the other hand, the flexible segment is calculated to register a CAGR of 8.3% during the forecast period.
By treatment, the market includes implant, surgery, and others. While in terms of diagnosis, the market includes physical examinations, x-rays, and others. Among these, the surgery segment is expected to lead the standings in terms of market during the assessment period. 
By end-users, the global market comprises hospitals, clinics, physiotherapy and orthopedic centers, and others. Herein, the hospital segment is anticipated to dominate the global market in the forthcoming years. 
By region, the hammertoe market covers North America, Europe, Asia Pacific, and the Middle East and Africa. 
Regional Analysis 
The regional market is led by North America in terms of market share in the global standings. The region is considered as one of the prime markets for foot and ankle surgery as well. The growth of the region can be attributed to the world-class healthcare infrastructure, rapid adoption of new products and treatments, and advanced medical facilities. With the availability of requisite products and skilled health professionals, and a high power of purchasing, the region is expected to expand in prolific manner in the near future. Moreover, some of the leading players functioning from this region are springing-in new innovation and developments in product to further ameliorate the growth of the market. 
Europe stands second in the global hammertoe market rankings. This is due to the advanced technology here and the fast-paced adoption of new devices. Western European nations like Germany, France, and the UK hold the maximum share of the overall region and contribute heavily to the growth of the regional market.
Asia Pacific is expected to be one of the fastest growing regions due to the fast-paced developing economy, changing healthcare industry, and increasing awareness concerning new products and treatments. Add to this, various profound initiatives have been undertaken by the government to enhance the health of the public. An expanding geriatric population coupled with cases of accidents are likely to propel the market growth in this region in the coming years.
Competitive Landscape
The global hammertoe market includes a number of key and prominent players like Stryker (U.S), BioPro (Michigan), Wright Medical Group N.V. (Memphis, TN), Arrowhead Medical Device Technologies LLC (Tennessee), Smith & Nephew (U.K), Extremity Medical LLC (U.S), Nextremity Solutions Inc. (U.S), and Zimmer Biomet Holdings (U.S).
March 12th, 2019, Nvision Biomedical Technologies’ Vector™ Hammertoe Correction System has been cleared for usage in the US by the Food and Drug Administration of America. It is the first ever ankle and foot implant that is made from advanced, biocompatible PEEK-OPTIMA™ HA Enhanced.
March 3rd, 2019, Centric Medical, a company specializing on developing surgical implants for treating distal extremity pathology, announced in a release the first clinical cases of the SATURN External Fixation System. The system is aimed at being used as a means for stabilizing bone segments for providing indications within the ankle and the foot. 
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com



Medical Implants Sterile Packaging Market Size 2025: Global Market Size, Competitive Landscape, and Key Country Analysis to 2023

According To MRFR Global Medical Implants Research Report: Information by Type (Orthopedic Implants, Cardiac Implants, Spinal Implants, Dental Implants, Ophthalmic Implants, Cosmetic Implants and others), Type of Material (Metallic Material, Ceramic Material, Polymers Material and others), End User (Hospitals & Clinics, Research Laboratories and others) and Region - Forecast till 2023
Medical implants are devices which are inserted into the body for functionality, monitoring, diagnostic, and therapeutic purposes. With a stress on responsiveness and design, polymers have been fronted as the obvious choice for the manufacture of these devices. The global medical implants market report by Market Research Future (MRFR) elaborates on various factors, drivers, opportunities, and challenges for the period between 2018 and 2023 (forecast period).
Market Outlook
The global medical implants sterile packaging market size is predicted to touch a top-notch value by exhibiting a CAGR of 7.50% during the forecast period. Rapid advances in scientific development, breakthroughs in materials, demand for better life, the large elderly populace, and chronic diseases are major factors which can drive market growth. Large number of diseases which can cause deficiencies will induce the demand for medical implants in the coming years.
Developments in nanomaterials and improvements in surgical outcomes can influence the global medical implants market demand. According to the FPA Sexual Charity in 2017, long-acting reversible contraceptive implants has been 99% effective with the immediate return of fertility after the removal of the device. Conduction of clinical trials for testing the efficacy and performance of medical implants to ensure rapid approval of the product can bode well for the market. Notable government initiatives such as the slashing of prices of medical implants in India can augur favorably for the global medical implants market.
Orthopedic implants are expected to gain tremendous traction due to osteoporosis-related cases and rising obesity. In addition, the large number of patients which opt for orthopedic implants are from the 55-80 demographic which can be lucrative for the global medical implants market. Moreover, emergence of 3D printing and computer-aided design (CAD) as possible solutions for doling out products at an expedited rate can make a positive impact on the market.
But the chances of failure of medical implants may dampen the market growth significantly.
Segmentation Analysis
The global medical implants market is segmented based on type, type of material, and end-user.
The global market for medical implants, by type is segmented into cosmetic implants, ophthalmic implants, orthopedic implants, cardiac implants, spinal implants, dental implants, and others.
The market, by type of material, is segmented into polymers material, ceramic material, metallic material, and others.
Based on end-user, the market is segmented into research laboratories, hospitals & clinics, and others.
Regional Analysis
The Middle East & Africa (MEA), Americas, Europe, and Asia Pacific (APAC) are major regions in the global medical implants market.
The Americas held a market share of 49.18% in 2017, followed by Europe and APAC. They are further divided into North America and South America. North America held a significant market share, while South America has the latent potential for explosive growth due to a large geriatric populace and the developments in healthcare infrastructure. Major factors driving the Americas medical implants market include the prevalence of chronic diseases, large number of surgeries, gigantic healthcare budget, and the ever-increasing numbers of the elderly populace.
The Europe region will be the second-biggest of the market with major contributions from Spain, Italy, France, U.K., and Germany. High healthcare spending, large geriatric populace, and supportive policies from the government.
The MEA region holds the least market share but is pegged to bloom during the forecast period. But the slow economic growth of certain countries in the African region can hamper the market growth.
Competitive Outlook
Stryker Corporation, 3M, Medtronic, Dentsply Sirona, Smith & Nephew, Zimmer Biomet Holdings, Inc., Institut Straumann AG, Boston Scientific Corporation, Johnson & Johnson Services, Inc., and others are reputed companies currently operating in the global medical implants market.
Read Complete Report odf Medical Implants Market With
170 Pages
165 Tables
10 Figure
 About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com 
NOTE : 
Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

AI in Drug Discovery Market is Expected to Demonstrate a High CAGR Between 2019-2025

AI in Drug Discovery Market Highlights
According to MRFR analysis, the Global AI in Drug Discovery Market is expected to register a CAGR of 40.8% during the forecast period of 2019 to 2025 and is anticipated to reach USD 2,015.1 Million by 2025.
The growth of the global AI in drug discovery market is driven by various factors such as investments by industry giants into the AI business, increasing number of startups operating in AI spectrum for healthcare including drug discovery, machine learning, and other AI technologies and increased use of AI technology by major pharma companies in the drug discovery. In addition, the increasing number of cross-industry partnerships for achieving the common goal of improvement in the drug development outcomes is another factor for the growth of the AI in the drug discovery market. Below is the chart representing the number of AI-driven deals each of the Big Biopharma companies have disclosed till March 2019.
However, the high cost of AI integration and lack of adequate infrastructure in low economy countries are thwarting the growth of the AI in the drug discovery market to some extent.
The global AI in the drug discovery market is expected to exhibit great growth potential in the future. Although there are few tech giants at the forefront of the AI technology at the moment, the competitive scenario is changing rapidly as the number of new entrants in the market is increasing continuously. As of February 2020, more than 200 startups have been operating in AI space for the healthcare sector.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region is expected to be the largest market owing to the number of big AI platform developers present in the region, such as Microsoft Azure, TensorFlow, and Google AI. The market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. Increasing demand for AI solutions by the pharmaceutical players such as AbbVie, Genentech, Amgen, and Eli Lilly and Company, among others, is pushing the market growth in the region. The European AI in drug discovery market is the second-largest market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. High demand for AI platforms and increasing integration into the drug discovery by major players such as Novartis, AstraZeneca, GSK, BI, BMS, and Sanofi, among others, are expected to drive the growth of AI in drug discovery market in the European region.
The AI in drug discovery market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to increasing R&D activities in the region and increasing adoption of the AI technologies by the pharma companies in countries like China and India, the market in Asia-Pacific is expected to grow at a significant rate during the forecast. The AI in drug discovery market in the Middle East & Africa has been divided into the Middle East and Africa.
Browse Full Report Details of AI in drug discovery market With 140 Page @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393